Enalare Therapeutics
Tom Miller, PhD, currently serves as the Senior Vice President of Clinical Development at Enalare Therapeutics Inc., where the focus is on developing novel therapies for acute respiratory conditions. In addition to this role, Tom Miller is the Principal Consultant at Clinical Strategies Consulting, LLC, and an Assistant Professor at Sidney Kimmel Medical College, where responsibilities include mentoring and consulting on research design. Previous positions include Executive Vice President of Clinical and Regulatory Affairs at Vixiar Medical and Director of Clinical and Scientific Affairs at Vapotherm. Tom Miller also managed the Infant Pulmonary Function Lab at Nemours and directed a translational research laboratory during a research scientist role. Educational credentials include a PhD in Pulmonary Physiology and an MEd in Physiology from Temple University, along with a BS in Kinesiology from the University of Delaware.
This person is not in any offices
Enalare Therapeutics
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.